| Bioactivity | Trifluoperazine-d8 is a deuterium labeled Trifluoperazine. Trifluoperazine is an antipsychotic phenothiazine agent and a selective α1-adrenergic receptor antagonist. Trifluoperazine is also a potent dopamine D2 receptor inhibitor [1][2]. |
| Target | α1-adrenergic receptorDopamine D2 receptor |
| Name | Trifluoperazine-d8 |
| Formula | C21H16D8F3N3S |
| Molar Mass | 415.54 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Huerta-Bahena J, et al. Trifluoperazine and chlorpromazine antagonize alpha 1- but not alpha2- adrenergic effects. Mol Pharmacol. 1983 Jan;23(1):67-70. [2]. Marques LO, et al. Trifluoperazine for schizophrenia. Cochrane Database Syst Rev. 2004;(1):CD003545. |
Trifluoperazine-d8
CAS: F: C21H16D8F3N3S W: 415.54
Trifluoperazine-d8 is a deuterium labeled Trifluoperazine. Trifluoperazine is an antipsychotic phenothiazine agent and a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.